文献速递新发突发、热带与寄生虫病医院感染防控

长效空间驱避剂在尼日利亚北部人道危机环境中抗疟的有效性:一项双臂实用性开放标签对照试验

The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trial.
PubMed 文献 · Lancet Infect Dis · 2026-01-08

在尼日利亚迈杜古里24个境内流离失所者营地开展6个月双臂实用性开放标签对照试验,纳入1655名6-10岁儿童。

要点

  • 显著降低拟除虫菊酯抗性雌性冈比亚按蚊密度和吸血率。

核心结论

  • 长效空间驱避剂可显著降低人道危机环境中儿童疟疾感染发病率。
  • 该产品为紧急人道环境中病媒控制工具箱提供新选择。
  • 首次提供西非空间驱避剂抗疟流行病学效力数据。

研究设计与样本

  • 6个月双臂实用性开放标签对照试验,在尼日利亚迈杜古里24个境内流离失所者营地开展。
  • 12个空间聚集营地分配至干预组,12个分配至对照组。
  • 干预组每营地50户按标签覆盖率安装长效空间驱避剂。
  • 每月队列纳入6-10岁儿童,共1655人(干预组842人,对照组813人)。
  • 按实际接受治疗分析,纳入所有非缺失观察,允许部分随访。

主要发现

  • 营地居民接受度高,由感知的病媒控制效果驱动,包括支付意愿。

临床怎么用

  • 在人道危机流离失所者营地中,可考虑使用长效空间驱避剂作为补充病媒控制工具。
  • 该干预对拟除虫菊酯抗性按蚊仍有效,适用于常规干预受限的紧急环境。
  • 实施时按产品标签覆盖率在住户安装,居民接受度高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2025, the UN estimated that 305 million people would need humanitarian aid, and by 2030, two-thirds of the poorest populations will reside in areas of fragility, conflict, and violence. When individuals are forcibly displaced into malaria endemic areas, the risk of severe disease and mortality can be high. Novel vector control tools suited to the emergency context, for which conventional interventions suffer from biological and operational limitations, are urgently needed to interrupt vector-borne disease transmission among the world's most vulnerable. This study aimed to evaluate the effectiveness of spatial repellent emanators against malaria during a protracted humanitarian crisis. METHODS: We conducted a 6-month, two-arm pragmatic, open-label, controlled trial in 24 camps for people who are internally displaced in Maiduguri, Nigeria. Children aged 6-10 years were enrolled into a monthly cohort to estimate the primary trial epidemiological outcome of intervention impact on malaria infection incidence. The study team allocated 12 camps, which were spatially clustered, to receive the intervention and 12 other camps were allocated to the control group and received no intervention. Spatial repellent emanators, designed to remain efficacious for trial duration, were installed by the study team, or the householder under supervision, at the label coverage, in 50 eligible households per camp allocated to the intervention group. Monthly entomological monitoring measured changes in vector density (primary entomological outcome) and blood feeding (secondary entomological outcome). Intervention acceptability and feasibility was assessed using focus group discussions (tertiary trial outcomes). Patients were analysed according to treatment received and analyses were conducted using all non-missing observations, allowing for inclusion of participants with partial follow-up. This trial was registered with ClinicalTrials.gov (NCT06179732) and is completed. FINDINGS: Between June 20 and July 3, 2023, 1655 participants were recruited, and 842 participants were assigned to the intervention group, and 813 patients were assigned to the control group. 770 patients were male and 885 were female. Post-intervention, after adjusting for baseline malaria prevalence, spatial repellent emanators significantly reduced malaria infection incidence over 6 months of follow-up (incidence rate ratio 0·713, 95% CI 0·584-0·869; p=0·001; n=1655). The estimated protective efficacy of spatial repellent emanators against first-time malaria infection was 22·5% (hazard ratio 0·775, 95% CI 0·637-0·943; p=0·011). Spatial repellent emanators also significantly reduced pyrethroid-resistant female Anopheles gambiae sensu lato density (incidence rate ratio 0·0231, 95% CI 0·00661-0·0807; p<0·0001) and blood feeding (0·0195, 0·00590-0·0646; p<0·0001). Camp residents displayed high levels of intervention acceptability, driven by perceived entomological impact, including willingness to pay. INTERPRETATION: These findings contribute to expanding the toolbox of efficacious vector control products for the humanitarian emergency context, strengthening the growing evidence for the public health value of spatial repellent emanators, and providing the first epidemiological efficacy data for spatial repellent emanators against malaria in west Africa. FUNDING: US Department of the Army, US Army Contracting Command, Aberdeen Proving Ground, Edgewood Contracting Division.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Allan RJ, Scherrer R, Estecha-Querol S, et al. The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trial. Lancet Infect Dis. 2026. PMID: 41520670. doi:10.1016/S1473-3099(25)00684-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。